Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-05-18 @ 3:02 AM
Study NCT ID:
NCT04638660
Status:
COMPLETED
Last Update Posted:
2025-10-14
First Post:
2020-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances
Sponsor:
Ocuphire Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OPI-NYXDLD-301 (LYNX-1)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None